Michael A Matthay Selected Research

Fibroblast Growth Factor 7

11/2017	Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction - a randomised placebo-controlled trial (KARE): study protocol.
1/2017	Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial.
8/2015	Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.
6/2014	Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury.
1/2014	Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice.
4/2013	Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria.
2/2013	Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction--a randomised placebo-controlled trial (KARE): study protocol.
5/2006	Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.
7/2002	Keratinocyte growth factor can enhance alveolar epithelial repair by nonmitogenic mechanisms.
5/2002	Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael A Matthay Research Topics

Disease

152	Acute Lung Injury 12/2021 - 01/2000
106	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 10/2022 - 01/2000
90	Lung Injury 06/2022 - 01/2000
74	Pulmonary Edema 01/2022 - 01/2002
54	Sepsis (Septicemia) 01/2022 - 04/2003
49	Inflammation (Inflammations) 01/2022 - 03/2002
40	Edema (Dropsy) 01/2021 - 02/2002
34	Pneumonia (Pneumonitis) 11/2021 - 05/2002
30	Critical Illness (Critically Ill) 06/2022 - 06/2002
22	COVID-19 10/2022 - 01/2020
21	Infections 11/2021 - 06/2002
18	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 06/2002
16	Hypoxia (Hypoxemia) 12/2020 - 11/2002
15	Wounds and Injuries (Trauma) 01/2022 - 09/2006
14	Lung Diseases (Lung Disease) 01/2022 - 05/2002
12	Acute Kidney Injury (Acute Renal Failure) 12/2020 - 07/2006
9	Shock 01/2022 - 12/2003
8	Human Influenza (Influenza) 11/2021 - 09/2014
8	Transfusion-Related Acute Lung Injury 11/2020 - 07/2004
7	Bacterial Pneumonia 11/2021 - 04/2006
7	Idiopathic Pulmonary Fibrosis 01/2020 - 03/2010
7	Septic Shock (Toxic Shock Syndrome) 12/2019 - 12/2004
6	Fibrosis (Cirrhosis) 07/2021 - 09/2003
6	Body Weight (Weight, Body) 08/2013 - 01/2000
6	Hyperoxia 01/2013 - 12/2003
4	Neoplasms (Cancer) 01/2022 - 03/2010
4	Asthma (Bronchial Asthma) 01/2022 - 05/2013
4	Ischemia 06/2008 - 06/2006
3	Viral Pneumonia 01/2021 - 05/2011
3	Thrombosis (Thrombus) 01/2021 - 10/2005
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021 - 04/2009
3	Dyspnea (Shortness of Breath) 01/2021 - 03/2004

Drug/Important Bio-Agent (IBA)

62	Biomarkers (Surrogate Marker)IBA 10/2022 - 01/2003
41	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2002
21	Protein CIBA 01/2021 - 04/2003
20	Interleukin-8 (Interleukin 8)IBA 01/2020 - 05/2002
18	CytokinesIBA 01/2022 - 11/2003
14	Interleukin-6 (Interleukin 6)IBA 01/2022 - 02/2004
13	Biological ProductsIBA 01/2022 - 10/2007
12	AntigensIBA 01/2022 - 07/2003
12	von Willebrand FactorIBA 01/2019 - 10/2004
11	ThrombomodulinIBA 01/2021 - 09/2003
10	EndotoxinsIBA 01/2022 - 08/2007
10	SodiumIBA 11/2021 - 07/2002
10	Therapeutic UsesIBA 11/2021 - 05/2012
10	Fibroblast Growth Factor 7 FDA Link 11/2017 - 05/2002
9	Oxygen (Dioxygen)IBA 01/2022 - 01/2003
9	Receptor for Advanced Glycation End ProductsIBA 01/2022 - 05/2006
9	Angiopoietin-2IBA 11/2021 - 09/2010
9	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 10/2012
9	SmokeIBA 01/2018 - 04/2007
8	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 10/2020 - 01/2003
8	LipopolysaccharidesIBA 01/2019 - 12/2004
8	Plasminogen Activator Inhibitor 1IBA 01/2017 - 07/2003
7	Indicators and Reagents (Reagents)IBA 01/2022 - 07/2009
7	CreatinineIBA 11/2020 - 12/2007
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2019 - 11/2003
7	Plasminogen Activators (Plasminogen Activator)IBA 01/2018 - 07/2003
7	Surface-Active Agents (Surfactants)IBA 01/2013 - 01/2003
7	Adrenergic beta-Agonists (beta-Adrenergic Agonists)IBA 02/2010 - 06/2002
6	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 05/2011
6	RNA (Ribonucleic Acid)IBA 11/2021 - 06/2015
6	Interleukin-10 (Interleukin 10)IBA 05/2017 - 01/2005
6	Peptide Hydrolases (Proteases)FDA Link 01/2016 - 08/2005
6	Blood Proteins (Serum Proteins)IBA 09/2012 - 05/2004
6	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2010 - 07/2003
6	AcidsIBA 07/2009 - 01/2002
5	Nicotine FDA Link 01/2022 - 11/2004
5	CatecholaminesIBA 01/2022 - 12/2004
5	Adrenergic Receptors (Adrenergic Receptor)IBA 05/2012 - 01/2005
4	LipidsIBA 08/2021 - 05/2006
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2020 - 03/2004
4	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 06/2014
4	GlucocorticoidsIBA 11/2018 - 05/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2015 - 06/2006
4	Albuterol (Salbutamol)FDA LinkGeneric 11/2014 - 06/2002
4	Epithelial Sodium ChannelsIBA 06/2014 - 12/2002
4	Amiloride (Midamor)FDA LinkGeneric 06/2014 - 12/2002
4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2014 - 05/2002
4	salicylhydroxamic acid (SHAM)IBA 02/2013 - 11/2003
4	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 05/2012 - 07/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2010 - 05/2006
4	FibrinIBA 01/2010 - 07/2004
4	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2009 - 11/2002
4	Messenger RNA (mRNA)IBA 01/2008 - 11/2002
4	ChloridesIBA 08/2007 - 07/2002
3	bamlanivimabIBA 01/2022 - 11/2021
3	Peptides (Polypeptides)IBA 11/2021 - 06/2006
3	CollagenIBA 07/2021 - 07/2013
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 12/2020

Therapy/Procedure

77	Therapeutics 01/2022 - 06/2004
34	Artificial Respiration (Mechanical Ventilation) 01/2021 - 01/2000
27	Mechanical Ventilators (Ventilator) 01/2018 - 01/2000
18	Critical Care (Surgical Intensive Care) 10/2022 - 07/2006
16	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 04/2002
10	Catheters 11/2020 - 10/2002
7	Transplantation 09/2020 - 11/2002
6	Extracorporeal Membrane Oxygenation 01/2022 - 08/2010
5	Length of Stay 01/2021 - 01/2005
5	Blood Transfusion (Blood Transfusions) 01/2018 - 05/2006